Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

York University (Toronto, Ontario)

$803,250.00

Dissecting the role of TRAF1 in regulating linear ubiquitination and the impact on inflammatory diseases

FY 2018-19

Summary
Excessive inflammation is the root cause of many debilitating human diseases, including heart disease, autoimmune diseases and cancer. Therefore, it's essential to identify and understand the mechanisms that keep inflammation in check. We recently reported a novel role of TRAF1, a signaling adapter protein, in controlling inflammation. We showed that people with a genetic variation in their TRAF1 make less TRAF1 protein, which loosens the "brakes" on their inflammatory cells and increases their risk of developing rheumatoid arthritis. However, therapies targeting TRAF1 in inflammatory and autoimmune diseases is complicated because TRAF1 plays additional, often opposing, roles in other immune pathways. Therefore, this proposal aims at dissecting the disparate TRAF1 functions, by identifying the sites of TRAF1 interaction with these pathways, and mutating them to affect one pathway at a time. This allows us to design therapies targeting specific TRAF1 functions that provides favorable therapeutic outcome for the aforementioned diseases.
Program
Project Grant
Location
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
389074
Name
Abdul Sater Ali
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology & Transplantation
Projecttitle
Dissecting the role of TRAF1 in regulating linear ubiquitination and the impact on inflammatory diseases
Programtype2
Operating Grants
Orgnameinp2
York University (Toronto, Ontario)
Cihramount2
$803,250
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Bone Marrow Chimera; Inflammasomes; Inflammation; Innate Immunity; Knockin Mouse; Linear Ubiquitintation; Rheumatoid Arthritis; Traf1
Abstract
Excessive inflammation is the root cause of many debilitating human diseases, including heart disease, autoimmune diseases and cancer. Therefore, it's essential to identify and understand the mechanisms that keep inflammation in check. We recently reported a novel role of TRAF1, a signaling adapter protein, in controlling inflammation. We showed that people with a genetic variation in their TRAF1 make less TRAF1 protein, which loosens the "brakes" on their inflammatory cells and increases their risk of developing rheumatoid arthritis. However, therapies targeting TRAF1 in inflammatory and autoimmune diseases is complicated because TRAF1 plays additional, often opposing, roles in other immune pathways. Therefore, this proposal aims at dissecting the disparate TRAF1 functions, by identifying the sites of TRAF1 interaction with these pathways, and mutating them to affect one pathway at a time. This allows us to design therapies targeting specific TRAF1 functions that provides favorable therapeutic outcome for the aforementioned diseases.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Abdul Sater, Ali
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $803,250~ $0~
York University (Toronto, Ontario) - $803,250 Grant (… | Canada Spends